{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:06:15Z","timestamp":1789016775073,"version":"build-2803163510"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejpb.2019.07.005","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:26:06Z","timestamp":1562354766000},"page":"364-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Rat intestinal drug permeability: A status report and summary of repeated determinations"],"prefix":"10.1016","volume":"142","author":[{"given":"I.R.","family":"Dubbelboer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0010","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.2042-7158.1997.tb06093.x","article-title":"Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms","volume":"49","author":"Fagerholm","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.005_b0020","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0025","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejpb.2019.07.005_b0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015927004752","article-title":"Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds","volume":"5","author":"Amidon","year":"1988","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.2042-7158.1998.tb07134.x","article-title":"Concentration-and region-dependent intestinal permeability of fluvastatin in the rat","volume":"50","author":"Lindahl","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.2042-7158.1997.tb06093.x","article-title":"Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms","volume":"49","author":"Fagerholm","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.07.005_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejps.2015.07.021","article-title":"Drug gastrointestinal absorption in rat: strain and gender differences","volume":"78","author":"Oltra-Noguera","year":"2015","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-loop doluisio (colon, small intestine) and single-pass intestinal perfusion (colon, jejunum) in rat-biophysical model and predictions based on Caco-2","volume":"35","author":"Lozoya-Agullo","year":"2017","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0055","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jps.2600691204","article-title":"Analysis of models for determining intestinal wall permeabilities","volume":"69","author":"Amidon","year":"1980","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-015-1773-4","article-title":"The effect of excipients on the permeability of BCS class III compounds and implications for biowaivers","volume":"33","author":"Parr","year":"2016","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejpb.2019.07.005_b0065","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/jps.2600581006","article-title":"Drug absorption I: an in situ rat gut technique yielding realistic absorption rates","volume":"58","author":"Doluisio","year":"1969","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0070","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","article-title":"Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods","volume":"104","author":"Dahlgren","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0080","first-page":"177","article-title":"Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ","volume":"11","author":"Abbasi","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.005_b0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejps.2017.05.012","article-title":"Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats","volume":"105","author":"Al Shaker","year":"2017","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.005_b0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/bdd.1809","article-title":"Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5","volume":"33","author":"Arakawa","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.005_b0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jphp.12551","article-title":"Effect of permeability enhancers on paracellular permeability of acyclovir","volume":"68","author":"Ates","year":"2016","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.005_b0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.18433\/J3MK72","article-title":"Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition","volume":"20","author":"Athukuri","year":"2017","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.005_b0105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/03639045.2017.1285310","article-title":"Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation","volume":"43","author":"Bedada","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pharep.2015.08.018","article-title":"Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: involvement of P-glycoprotein inhibition","volume":"68","author":"Bedada","year":"2016","journal-title":"Pharm. Rep.: PR"},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejps.2003.12.004","article-title":"Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models","volume":"21","author":"Berggren","year":"2004","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-3565(24)29265-X","article-title":"Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter","volume":"299","author":"Chu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1211\/002235702955","article-title":"Estimation of absorption parameters from the non-steady-state phase in the rat gut perfusion model","volume":"55","author":"Corrigan","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejpb.2019.07.005_b0130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1023\/A:1011940108365","article-title":"In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin","volume":"15","author":"Crowe","year":"1998","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.102.044719","article-title":"In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model","volume":"305","author":"Cummins","year":"2003","journal-title":"J. Pharm. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/mp800088f","article-title":"Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs","volume":"6","author":"Dahan","year":"2009","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11095-008-9789-7","article-title":"Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of P-glycoprotein","volume":"26","author":"Dahan","year":"2009","journal-title":"Pharm. Res."},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2019.07.005_b0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejps.2008.10.013","article-title":"Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat","volume":"36","author":"Dahan","year":"2009","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.005_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2016.04.020","article-title":"Single-Pass Intestinal Perfusion (SPIP) and prediction of fraction absorbed and permeability in humans: A study with antiretroviral drugs","volume":"104","author":"Dezani","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-201x.1999.00510.x","article-title":"Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag","volume":"165","author":"Fagerholm","year":"1999","journal-title":"Acta Physiol. Scand."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2016.10.064","article-title":"In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles","volume":"516","author":"Garg","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13318-011-0059-4","article-title":"In vitro\u2013in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate","volume":"37","author":"Gundogdu","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(00)00195-0","article-title":"Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats","volume":"12","author":"Hanafy","year":"2001","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.005_b0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejps.2017.02.009","article-title":"Enhanced oral bioavailability of docetaxel in rats combined with myricetin: in situ and in vivo evidences","volume":"101","author":"Hao","year":"2017","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.005_b0190","first-page":"472","article-title":"Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein","volume":"71","author":"Incecayir","year":"2016","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0195","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/mp300410n","article-title":"Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification","volume":"10","author":"Incecayir","year":"2013","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0200","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1208\/pt040216","article-title":"Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note","volume":"4","author":"Issa","year":"2003","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2019.07.005_b0205","first-page":"1","article-title":"Intestinal permeability of mitragynine in rats using in situ absorption model","author":"Jagabalan","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2006.11.058","article-title":"Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats","volume":"336","author":"Jain","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/03639045.2011.619194","article-title":"In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system","volume":"38","author":"Kang","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0220","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s11095-012-0768-7","article-title":"Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography","volume":"29","author":"Kataoka","year":"2012","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.005_b0225","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp060042f","article-title":"The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests","volume":"3","author":"Kim","year":"2006","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0230","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.301.2.586","article-title":"Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat","volume":"301","author":"Li","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0240","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1012187730907","article-title":"Is the jejunal permeability in rats age-dependent?","volume":"14","author":"Lindahl","year":"1997","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0245","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.2042-7158.1998.tb07134.x","article-title":"Concentration- and region-dependent intestinal permeability of fluvastatin in the rat","volume":"50","author":"Lindahl","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0250","first-page":"43","article-title":"Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability","volume":"2","author":"Loveymi","year":"2012","journal-title":"Adv. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0255","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/jps.24447","article-title":"In situ perfusion model in rat colon for drug absorption studies: comparison with small intestine and Caco-2 cell model","volume":"104","author":"Lozoya-Agullo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.005_b0260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejps.2016.08.035","article-title":"Development of an ion-pair to improve the colon permeability of a low permeability drug: atenolol","volume":"93","author":"Lozoya-Agullo","year":"2016","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2017.05.018","article-title":"Investigating drug absorption from the colon: single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion","volume":"527","author":"Lozoya-Agullo","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.01.014","article-title":"In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches","volume":"480","author":"Lozoya-Agullo","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2019.07.005_b0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2006.06.004","article-title":"Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract","volume":"29","author":"Masaoka","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15171\/apb.2016.017","article-title":"The effects of cetirizine on P-glycoprotein expression and function in vitro and in situ","volume":"6","author":"Mesgari Abbasi","year":"2016","journal-title":"Adv. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0285","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1208\/s12249-018-0982-7","article-title":"Biowaiver or bioequivalence: ambiguity in sildenafil citrate BCS classification","volume":"19","author":"Miranda","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijpharm.2014.11.027","article-title":"Intestinal uptake and toxicity evaluation of acetazolamide and its multicomponent complexes with hidroxypropyl-beta-cyclodextrin in rats","volume":"478","author":"Mora","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/0250-474X.78533","article-title":"Determination of site of absorption of propranolol in rat gut using in situ single-pass intestinal perfusion","volume":"72","author":"Nagare","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharep.2014.09.010","article-title":"Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats","volume":"67","author":"Neerati","year":"2015","journal-title":"Pharm. Rep.: PR"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2011.05.005","article-title":"Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats","volume":"44","author":"Neerati","year":"2011","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07420528.2012.668996","article-title":"Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance","volume":"29","author":"Okyar","year":"2012","journal-title":"Chronobiol. Int."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/mp500553b","article-title":"Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification","volume":"12","author":"Ozawa","year":"2015","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0320","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/0250-474X.108441","article-title":"Intestinal permeability of Lamivudine using single pass intestinal perfusion","volume":"74","author":"Patel","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1211\/0022357055786","article-title":"Investigation of oral bioavailability and brain distribution of the Ind(8)-Val conjugate of indinavir in rodents","volume":"57","author":"Pereira de Oliveira","year":"2005","journal-title":"J. Pharm. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0330","doi-asserted-by":"crossref","first-page":"138","DOI":"10.18433\/J36W2J","article-title":"In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay","volume":"14","author":"Rabba","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"4\u20135","key":"10.1016\/j.ejpb.2019.07.005_b0335","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejps.2012.12.025","article-title":"Lamivudine permeability study: a comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum","volume":"48","author":"Reis","year":"2013","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0340","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0939-6411(02)00185-6","article-title":"Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies","volume":"55","author":"Rodr\u0131guez-Ib\u00e1nez","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2005.09.014","article-title":"Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin","volume":"307","author":"Rodr\u00edguez-Ib\u00e1\u00f1ez","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0350","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jps.23807","article-title":"Hydroxypropyl-sulfobutyl-beta-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes","volume":"103","author":"Rong","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0355","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/acs.molpharmaceut.7b00294","article-title":"In vivo mechanisms of intestinal drug absorption from aprepitant nanoformulations","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0360","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: a comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.005_b0365","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejps.2017.06.033","article-title":"Comparison of segmental-dependent permeability in human and in situ perfusion model in rat","volume":"107","author":"Ruiz-Picazo","year":"2017","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0370","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1211\/0022357011776252","article-title":"Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man","volume":"53","author":"Salphati","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0375","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.2042-7158.1998.tb07133.x","article-title":"The absence of stereoselective P-glycoprotein-mediated transport of R\/S-verapamil across the rat jejunum","volume":"50","author":"Sandstr\u00f6m","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.109.159756","article-title":"Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat","volume":"332","author":"Shirasaka","year":"2010","journal-title":"J. Pharm. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0385","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11095-008-9771-4","article-title":"Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp)","volume":"26","author":"Shirasaka","year":"2009","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ejpb.2019.07.005_b0390","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-010-0216-5","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide","volume":"27","author":"Shirasaka","year":"2010","journal-title":"Pharm. Res."},{"issue":"25","key":"10.1016\/j.ejpb.2019.07.005_b0395","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.3748\/wjg.v12.i25.4064","article-title":"Intestinal permeability of metformin using single-pass intestinal perfusion in rats","volume":"12","author":"Song","year":"2006","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0400","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12272-013-0202-7","article-title":"In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system","volume":"37","author":"Song","year":"2014","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0405","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1023\/A:1016207525186","article-title":"Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans","volume":"12","author":"Stewart","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.005_b0410","first-page":"328769","article-title":"Self-Microemulsifying drug delivery system: formulation and study intestinal permeability of ibuprofen in rats","volume":"2013","author":"Subudhi","year":"2013","journal-title":"J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.005_b0415","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3109\/03639045.2014.925918","article-title":"Corroboration of naringin effects on the intestinal absorption and pharmacokinetic behavior of candesartan cilexetil solid dispersions using in-situ rat models","volume":"41","author":"Surampalli","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-9556(24)15281-6","article-title":"High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement","volume":"27","author":"Svensson","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0425","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0022-3565(24)37527-5","article-title":"A new interpretation of salicylic acid transport across the lipid bilayer: implications of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract","volume":"285","author":"Takagi","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0430","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jps.10041","article-title":"Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats","volume":"91","author":"Tamura","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0435","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.103.050716","article-title":"The site-specific transport and metabolism of tacrolimus in rat small intestine","volume":"306","author":"Tamura","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0440","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1023\/A:1015843517762","article-title":"Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size","volume":"6","author":"Tarr","year":"1989","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.005_b0445","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/03639045.2013.851210","article-title":"Effect of anionic macromolecules on intestinal permeability of furosemide","volume":"41","author":"Valizadeh","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0450","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jaoac\/89.1.88","article-title":"A simple and rapid high-performance liquid chromatography method for determining furosemide, hydrochlorothiazide, and phenol red: applicability to intestinal permeability studies","volume":"89","author":"Valizadeh","year":"2006","journal-title":"J. AOAC Int."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0455","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchromb.2004.09.047","article-title":"Simultaneous determination of digoxin and permeability markers in rat in situ intestinal perfusion samples by RP-HPLC","volume":"813","author":"Varma","year":"2004","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0460","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/bmc.781","article-title":"Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatography\/UV detection","volume":"21","author":"Venkatesh","year":"2007","journal-title":"Biomed. Chromatogr.: BMC"},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.005_b0465","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ptr.3704","article-title":"Effect of pomegranate juice on intestinal transport and pharmacokinetics of nitrendipine in rats","volume":"26","author":"Voruganti","year":"2012","journal-title":"Phytother. Res.: PTR"},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0470","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/AAC.01382-13","article-title":"Investigation of the functional role of P-glycoprotein in limiting the oral bioavailability of lumefantrine","volume":"58","author":"Wahajuddin","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2019.07.005_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2012.03.048","article-title":"Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: application to prove the cassette administration principle in single pass intestinal perfusion study in rats","author":"Wahajuddin","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.ejpb.2019.07.005_b0480","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/A:1012174217220","article-title":"Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach","volume":"14","author":"Wang","year":"1997","journal-title":"Pharm. Res."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2019.07.005_b0485","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jpba.2005.04.008","article-title":"Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation","volume":"39","author":"Zakeri-Milani","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2019.07.005_b0490","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.colsurfb.2012.10.021","article-title":"The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system","volume":"103","author":"Zakeri-Milani","year":"2013","journal-title":"Colloids Surf. B, Biointerfaces"},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.005_b0495","first-page":"188","article-title":"Investigation of the intestinal permeability of ciclosporin using the in situ technique in rats and the relevance of P-glycoprotein","volume":"58","author":"Zakeri-Milani","year":"2008","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0500","first-page":"368","article-title":"Predicting human intestinal permeability using single-pass intestinal perfusion in rat","volume":"10","author":"Zakeri-Milani","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0505","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3109\/03639040903037199","article-title":"The utility of rat jejunal permeability for biopharmaceutics classification system","volume":"35","author":"Zakeri-Milani","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0510","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13318-012-0106-9","article-title":"Effects of pyridoxine on the intestinal absorption and pharmacokinetics of isoniazid in rats","volume":"38","author":"Zhou","year":"2013","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0515","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/mp500152y","article-title":"The low\/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol","volume":"11","author":"Zur","year":"2014","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.005_b0520","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0928-0987(95)00027-B","article-title":"Experimental estimation of the effective unstirred water layer thickness in the human jejunum, and its importance in oral drug absorption","volume":"3","author":"Fagerholm","year":"1995","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0530","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/acs.molpharmaceut.6b00515","article-title":"Regional intestinal permeability in dogs: biopharmaceutical aspects for development of oral modified-release dosage forms","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0535","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2125.1993.tb05691.x","article-title":"The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man","volume":"35","author":"Lennernas","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.07.005_b0540","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0009-9236(96)90208-8","article-title":"Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies","volume":"60","author":"Hellriegel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2019.07.005_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2019.06.011","article-title":"Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model","author":"Dahlgren","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0550","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: a comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0555","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-201X.1996.530287000.x","article-title":"Comparative study of the effects of nitric oxide synthase and cyclo-oxygenase inhibition on duodenal functions in rats anaesthetized with inactin, urethane or a-chloralose","volume":"158","author":"Sababi","year":"1996","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0560","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2005.11.016","article-title":"Effect of intestinal fluid flux on ibuprofen absorption in the rat intestine","volume":"309","author":"Lane","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0565","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/mp100175a","article-title":"High-permeability criterion for BCS classification: segmental\/pH dependent permeability considerations","volume":"7","author":"Dahan","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.005_b0570","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2016.09.061","article-title":"Segmental-dependent permeability throughout the small intestine following oral drug administration: single-pass vs. Doluisio approach to in-situ rat perfusion","volume":"515","author":"Lozoya-Agullo","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.005_b0575","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.005_b0580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00580717","article-title":"pH-microclimate at the luminal surface of the intestinal mucosa of guinea pig and rat","volume":"407","author":"Rechkemmer","year":"1986","journal-title":"Pfl\u00fcgers Archiv."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.005_b0585","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/apha.12201","article-title":"Prevention of duodenal ileus reveals functional differences in the duodenal response to luminal hypertonicity in Sprague-Dawley and Dark Agouti rats","volume":"210","author":"Sedin","year":"2014","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejpb.2019.07.005_b0590","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","author":"Sj\u00f6berg","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0595","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1016\/j.xphs.2016.03.010","article-title":"Interlaboratory validation of small-scale solubility and dissolution measurements of poorly water-soluble drugs","volume":"105","author":"Andersson","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.005_b0600","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of model compounds and the mucosal barrier marker 51Cr-EDTA","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.005_b0605","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.molpharmaceut.6b00514","article-title":"Regional intestinal permeability of three model drugs in human","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119302498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119302498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:36Z","timestamp":1760546316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119302498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":121,"alternative-id":["S0939641119302498"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.005","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rat intestinal drug permeability: A status report and summary of repeated determinations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}